Mckesson Stock Shows Rising Relative Strength; Still Shy Of Key Threshold

Mckesson (MCK) saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 68 to 71. Decades of market research reveals that the best-performing stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Mckesson stock can continue to rebound and hit that benchmark.


When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD’s proprietary rating identifies share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price behavior over the last 52 weeks compares to all the other stocks in our database.

Looking For Winning Stocks? Try This Simple Routine


McKesson is an U.S.-based company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

Mckesson Stock Works On A Base

Irving, Texas-based Mckesson is working on a flat base with a 210.10 buy point. See if it can clear the breakout price in heavy volume.

Earnings grew 101% last quarter, up from 18% in the prior report. Revenue also increased, from 1% to 13%.

Mckesson stock earns the No. 1 rank among its peers in the Medical-Wholesale Drugs industry group.


Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Identify Bases And Buy Points With Pattern Recognition From MarketSmith

Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button